首页 | 本学科首页   官方微博 | 高级检索  
     

替米沙坦联合阿魏酸钠治疗糖尿病肾病的临床观察
引用本文:周汉明. 替米沙坦联合阿魏酸钠治疗糖尿病肾病的临床观察[J]. 亚太传统医药, 2011, 7(9): 104-105
作者姓名:周汉明
作者单位:武汉市第三医院药学部,湖北武汉,430060
摘    要:目的:探讨替米沙坦联合阿魏酸钠治疗糖尿病肾病的方法及疗效。方法:将2009年1月—2011年1月我院收治的糖尿病肾病患者76例随机分为观察组38例(替米沙坦联合阿魏酸钠治疗)和对照组38例(替米沙坦治疗),对两组治疗情况进行比较。结果:两组患者治疗前后的UAER相比差异均具有显著性(P<0.05)。治疗后观察组Scr显著下降(P<0.05),而对照组则无明显变化,治疗后FBG、BUN均无明显变化。结论:替米沙坦联合阿魏酸钠治疗糖尿病肾病疗效明显,值得临床推广应用。

关 键 词:替米沙坦  阿魏酸钠  糖尿病肾病

Telmisartan Joint Ferulic Acid Sodium Clinical Observationof the Treatment of Diabetic Nephropathy
Zhou Hanming. Telmisartan Joint Ferulic Acid Sodium Clinical Observationof the Treatment of Diabetic Nephropathy[J]. Asia-Pacific Traditional Medicine, 2011, 7(9): 104-105
Authors:Zhou Hanming
Affiliation:Zhou Hanming(The third Hospital of Wuhan,Wuhan 430060,China)
Abstract:Objective:telmisartan joint ferulic acid sodium treatment of diabetic nephropathy method and clinical effect.Methods:in January 2009 from January through 2011 drug-induced diabetes nephrosis patient 76 cases were randomly divided into trial group(38 cases telmisartan joint ferulic acid sodium treatment) and the control group(38 cases telmisartan treatment),the two groups of treatment to compare.Results:two groups of patients before and after treatment were compared UAER significant difference(P<0.05).After ...
Keywords:Telmisartan  Ferulic Acid Sodium  Diabetic Nephropathy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号